The CEO of Max Zeller, a Swiss Phytopharmaceutical company, highlights the immense benefits his products have and furthermore discusses the company’s internationalization strategy.
Mr Boonen, you joined Max Zeller in June 1999 and have spent almost all your professional career here. How have you seen the company evolve over time and how would you define what it is today?
"Today, in our women’s health portfolio, we are market leader in Switzerland for treatment of the menopause. From a niche product, we have successfully turned it into “standard therapy”."
